Insights On Clinical Technologies

  1. How AI-Enhanced CAPA Systems Actually Work 11/6/2025

    Learn how AI can accelerate root cause analysis, predict quality risks, and streamline CAPA without compromising compliance or overwhelming your team with practical strategies.

  2. Avoid Database Go-Live Delays With The Right EDC System 10/4/2024

    If you are looking to speed up your start-up process, selecting a reliable EDC System is key.

  3. Perspective On The FDA's Final Digital Health Technologies Guidance 1/24/2024

    Review the final release of "Digital Health Technologies for Remote Data Acquisition in Clinical Investigations”, where the FDA acknowledges DHT value and the increasing use of them in clinical trials.

  4. Drive Superior Enrollment, Speed, And Quality Using eSource 1/3/2025

    Explore a detailed analysis of 140 research sites involved in a Phase III trial, highlighting significant advancements in trial performance and data quality using CRIO’s eSource platform.

  5. Digitizing And Standardizing Participant Pain Body Maps 6/13/2024

    Explore how digitizing clinical trial processes, such as paperless "body map" assessments, can enhance efficiency and standardization in pharmaceutical trials.

  6. Clinical Trial Disclosure Fundamentals 11/7/2025

    Failing to comply with disclosure rules can leave sponsors open to fines and penalties. Here, we present the latest disclosure requirements, enforcement mechanisms, and tips on how best to stay compliant.

  7. From Startup To Public Company: Scaling Finance Operations 11/14/2024

    When basic tools no longer support your growing company, robust systems, such as ERPs, become essential for managing complex financial reporting, regulatory compliance, and multi-entity tracking.

  8. Innovations In Pediatric Depression Assessment 6/17/2025

    Discover the transformation of a complex assessment challenge into a competitive advantage. Our electronic CDRS-R doesn't just digitize the scale—it embeds clinical expertise, automates quality controls, and guides raters through every step to ensure consistent, reliable data.

  9. Letter From The CEO: A New Era Of Drug Development Is Here 9/3/2024

    This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.

  10. Leveraging Real-World Data And AI To Broaden Patient Diversity 10/16/2024

    The convergence of recent technological advancements and diversity action plans holds great promise for creating more inclusive oncological clinical trials.